TWIST1 and acute myeloid leukemia: For those attaining CR, Twist1-overexpressing AML patients did so with fewer cycles of induction chemotherapy than those with low Twist1 activity (mean cycles of chemotherapy to CR: 1.1±0.3 vs 1.8±1.2, respectively, P=0.037, Table 2).